Polypharmacy clinical trials

Explore recruiting polypharmacy clinical trials.

Recruiting polypharmacy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Polypharmacy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY) – a phase III Trial

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Polypharmacy trials by city

Polypharmacy in Toronto Polypharmacy in Vancouver Polypharmacy in Montreal Polypharmacy in Calgary Polypharmacy in Edmonton Polypharmacy in Ottawa Polypharmacy in Winnipeg Polypharmacy in Quebec City Polypharmacy in Hamilton Polypharmacy in Kitchener Polypharmacy in London Polypharmacy in Halifax Polypharmacy in New York Polypharmacy in Los Angeles Polypharmacy in Chicago Polypharmacy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease